BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2526959)

  • 41. Long-term comparison of salbutamol powder with salbutamol aerosol in asthmatic out-patients.
    Hartley JP; Nogrady SG; Seaton A
    Br J Dis Chest; 1979 Jul; 73(3):271-6. PubMed ID: 399858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bronchodilator effect of inhaled olprinone, a phosphodiesterase 3 inhibitor, in asthmatic patients.
    Myou S; Fujimura M; Kamio Y; Ishiura Y; Tachibana H; Hirose T; Hashimoto T; Matsuda T
    Am J Respir Crit Care Med; 1999 Sep; 160(3):817-20. PubMed ID: 10471602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparative therapeutic effect of bronchodilator aerosols and salbutamol cyclocaps].
    Ninković M; Bjelajac D; Ranković B; Dangubić V; Plavec G
    Vojnosanit Pregl; 1993; 50(6):589-92. PubMed ID: 8197732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative study of carbuterol and salbutamol from metered aerosols in bronchial asthma.
    Beumer HM; Mills JG; Sharpe PC
    Respiration; 1978; 35(4):220-3. PubMed ID: 345380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical evaluation of procaterol and salbutamol in patients with bronchial asthma].
    Płusa T; Zaraś E; Kruszewski J
    Pneumonol Alergol Pol; 1992; 60(11-12):48-52. PubMed ID: 1303778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison between fenoterol and salbutamol in asthmatic patients.
    Palma-Carlos AG; Barbosa MA
    Allergol Immunopathol (Madr); 1977; 5(3):227-30. PubMed ID: 329664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Formoterol and salbutamol metered aerosols: comparison of a new and an established beta-2-agonist for their bronchodilating efficacy in the treatment of childhood bronchial asthma.
    von Berg A; Berdel D
    Pediatr Pulmonol; 1989; 7(2):89-93. PubMed ID: 2797925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of exercise-induced bronchospasm in asthmatic children. Effect of aerosol and oral procaterol hydrochloride.
    Morooka T; Nishima S; Ota S
    J Asthma; 1987; 24(6):335-46. PubMed ID: 2965139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of inhaled procaterol hydrochloride in children with bronchial asthma, with particular reference to duration of effect.
    Mitsuhashi M; Kimura T; Tateno K; Morikawa A; Kuroume T
    J Asthma; 1985; 22(4):203-7. PubMed ID: 2931421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A placebo-controlled trial of procaterol: a new long-acting oral beta 2-agonist in bronchial asthma.
    Siegel SC; Katz RM; Rachelefsky GS; Brandon ML; Borgen LA
    J Allergy Clin Immunol; 1985 Jun; 75(6):698-705. PubMed ID: 2861219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative study of acute effects of albuterol and isoproterenol sulphate aerosols in bronchial asthma.
    Mahajan VK; Tomashefski JF; Huber GL
    Ann Allergy; 1977 Nov; 39(5):319-24. PubMed ID: 335924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative study of a new selective beta 2-adrenoceptor agonist, procaterol and salbutamol in asthma.
    Crowe MJ; Counihan HE; O'Malley K
    Br J Clin Pharmacol; 1985 Jun; 19(6):787-91. PubMed ID: 2862893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of bronchodilator and extrabronchial action of salbutamol Polfa-aerosol in comparison with Ventolin Pliva, Berotec Boehringer Ingelheim and Astmopent Polfa in patients with chronic obstructive bronchitis.
    Roźniecki J; Gondorowicz K; Szmidt M; Grabski W
    Mater Med Pol; 1978; 10(2):139-45. PubMed ID: 703389
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of procaterol treatment on beta-adrenergic bronchodilation and polymorphonuclear leukocyte responsiveness.
    Busse WW; Sharpe G; Smith A; Arbabian M; Borgen L; Ruoho A
    Am Rev Respir Dis; 1985 Dec; 132(6):1194-8. PubMed ID: 3000233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aerosolised bronchodilator therapy with & without IPPR in bronchial asthma--a comparative evaluation.
    Gupta S; Poddar SP; Nath S
    Indian J Chest Dis Allied Sci; 1978 Jul; 20(3):118-25. PubMed ID: 363611
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of oral salbutamol and pirbuterol on FEV1, heart rate and blood pressure in asthmatics.
    Willey RF; Grant IW; Pocock SJ
    Br J Clin Pharmacol; 1976 Aug; 3(4):595-600. PubMed ID: 22216500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does a beta 2-stimulator really facilitate mucociliary transport in the human lungs in vivo? A study with procaterol.
    Isawa T; Teshima T; Hirano T; Anazawa Y; Miki M; Konno K; Motomiya M
    Am Rev Respir Dis; 1990 Mar; 141(3):715-20. PubMed ID: 1968734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pirbuterol in the treatment of bronchial asthma.
    Beumer HM
    Int J Clin Pharmacol Biopharm; 1979 Jan; 17(1):18-25. PubMed ID: 367975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Double-blind crossover study of carbuterol and salbutamol in bronchial asthma.
    Misra NP; Tiwari UC; Khemchandani GT
    J Int Med Res; 1981; 9(4):261-7. PubMed ID: 6114884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Double-blind trial with standard doses of fenoterol and salbutamol in asthmatic children.
    Graff-Lonnevig V
    Acta Allergol; 1976 Dec; 31(6):463-70. PubMed ID: 797215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.